ADNH (ADNH) Stock Price & Analysis
ADNH (ADNH) rose 0.00% to USD 0 as of September 8, 2026 at 22:12 UTC, according to Nexqual real-time market data.
ADNH last closed at USD 0; the session ranged USD 0.32–0.36 on volume of 7,186 shares. Market capitalization is —, with a 52-week range of USD 0–3.99 (PNK). Source: Nexqual, September 8, 2026 at 22:12 UTC.
Key Statistics (as of September 8, 2026 at 22:12 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0.32 – 0.36 |
| 52-Week Range | USD 0 – 3.99 |
| Volume | 7,186 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (ADNH)
Nexqual's technical model rates ADNH "SELL" based on 2 bullish and 5 bearish signals across 127 daily candles, as of September 8, 2026 at 22:12 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 2.22 (oversold) |
| vs SMA50 | Below (USD 0.12) |
| MACD | -0.03 (negative) |
From ADNH's Latest SEC 10-K Filing (filed 2025-06-06)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ENSC | Ensysce Biosciences, Inc. | USD 0.47 | ▲ 7.5% |
| AREB | American Rebel Holdings, Inc. | USD 0.16 | ▲ 3.97% |
| SBFM | Sunshine Biopharma Inc. | USD 1.15 | ▲ 3.6% |
| REVB | Revelation Biosciences, Inc. | USD 1.01 | ▲ 0% |
| KAVL | Kaival Brands Innovations Group | USD 0.02 | ▲ 6.96% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 22:12 UTC. This page is informational and not investment advice.